🇺🇸 FDA
Patent

US 11542248

Methods and compositions for inhibiting the interaction of menin with MLL proteins

granted A61KA61K38/00A61K9/0019

Quick answer

US patent 11542248 (Methods and compositions for inhibiting the interaction of menin with MLL proteins) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61K9/0019, A61K9/0053, A61P